On the Organization of a Drug Discovery Platform

J. Boutin, O. Nosjean, G. Ferry
{"title":"On the Organization of a Drug Discovery Platform","authors":"J. Boutin, O. Nosjean, G. Ferry","doi":"10.5772/INTECHOPEN.73170","DOIUrl":null,"url":null,"abstract":"Some of the most exciting parts of work in the pharmaceutical industry are the steps lead- ing up to drug discovery. This process can be oversimplified by describing it as a screen ing campaign involving the systematic testing of many compounds in a test relevant to a given pathology. This naïve description takes place without taking into consideration the numerous key steps that led up to the screening or the steps that might follow. The present chapter describes this whole process as it was conducted in our company during our early drug discovery activities. First, the purpose of the procedures is described and rationalized. Next follows a series of mostly published examples from our own work illustrating the various steps of the process from cloning to biophysics, including expression systems and membrane-bound protein purifications. We believe that what is described here presents an example of how pharmaceutical industry research can orga- nize its platform(s) when the goal is to find and qualify a new preclinical drug candidate using cutting-edge technologies and a lot of hard work.","PeriodicalId":191867,"journal":{"name":"Drug Discovery - Concepts to Market","volume":"28 3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery - Concepts to Market","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/INTECHOPEN.73170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Some of the most exciting parts of work in the pharmaceutical industry are the steps lead- ing up to drug discovery. This process can be oversimplified by describing it as a screen ing campaign involving the systematic testing of many compounds in a test relevant to a given pathology. This naïve description takes place without taking into consideration the numerous key steps that led up to the screening or the steps that might follow. The present chapter describes this whole process as it was conducted in our company during our early drug discovery activities. First, the purpose of the procedures is described and rationalized. Next follows a series of mostly published examples from our own work illustrating the various steps of the process from cloning to biophysics, including expression systems and membrane-bound protein purifications. We believe that what is described here presents an example of how pharmaceutical industry research can orga- nize its platform(s) when the goal is to find and qualify a new preclinical drug candidate using cutting-edge technologies and a lot of hard work.
论药物发现平台的组织
制药行业工作中最令人兴奋的部分是通向药物发现的步骤。这一过程可能被过分简化,因为它是一项筛选活动,涉及在与给定病理相关的测试中对许多化合物进行系统测试。这个naïve描述是在没有考虑到导致筛选的众多关键步骤或随后可能采取的步骤的情况下进行的。本章描述了整个过程,因为它是在我们公司的早期药物发现活动中进行的。首先,对程序的目的进行了描述和合理化。接下来是我们自己的一系列主要发表的例子,说明了从克隆到生物物理学过程的各个步骤,包括表达系统和膜结合蛋白纯化。我们认为,这里所描述的是一个例子,说明制药行业研究如何组织其平台,当目标是使用尖端技术和大量的辛勤工作来寻找和鉴定新的临床前候选药物时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信